Project description
Simple, accessible early cancer detection
Cancer caught early can be treated effectively, resulting in survival rates of over 80 per cent. If it isn't, then survival rates drop as low as 17 per cent. More than half of the cancer deaths recorded to date are due to the lack of preventive testing. Costly MRI imagery, for example, lacks detection capability until cancer symptoms and tumour growths set in. Metachip, produced by ConquerX, is a revolutionary pan-cancer diagnostic platform that enables early-stage detection for the 10 most common types of cancer. Metachip is a diagnostic software suite powered by cutting edge artificial intelligence. It is cost effective and administered through a single, simple blood test that does not require special lab facilities and analytic techniques.
Objective
Cancer is the second highest cause of death in the EU, with more than 1.3 million deaths attributable to cancer each year. Early detection of cancer is crucial to increasing the chances of survival for patients. For example, the average cancer survival rate is 83% when caught early and only 17% when diagnosed at an advanced stage. This is compounded by the difficulty and expense of screening for early stage cancers. Beyond expensive and specialist whole body imaging techniques such as MRI, there is still no commercially available general test for detecting any type of cancer before symptoms present themselves. Staggeringly, 52% of cancer deaths are due to a lack of preventative tests. Metachip, from ConquerX, is a revolutionary pan-cancer diagnostic platform that enables early-stage detection of the 10 most common types of cancer from a single, simple blood test. The platform consists of a reading device, disposable chips coated with a proprietary nanocomposite, and a diagnostic software suite powered by cutting edge artificial intelligence. The Metachip test is cost effective, fast (one hour to results), and does not require specialist analytical techniques or lab facilities. By delivering the Metachip platform, ConquerX aim to make early-stage detection of cancer available to every hospital in the EU and worldwide. During the phase 1 feasibility study, ConquerX will establish a sound go-to-market strategy and supply chain, and will draft further development plans. During the second phase of the innovation project, ConquerX will optimise the diagnostic platform, scale-up manufacturing, perform clinical validation activities with partner hospitals and gain regulatory approval.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences artificial intelligence edge artificial intelligence
- medical and health sciences clinical medicine oncology
- engineering and technology medical engineering medical laboratory technology laboratory samples analysis
- natural sciences computer and information sciences artificial intelligence machine learning
- engineering and technology materials engineering nanocomposites
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
E9 5EN LONDON
United Kingdom
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.